Sepsis is killing over 45 million people a year with no definitive diagnostic in hand. And now the COVID Pandemic has increased the sepsis death toll.  The race is on using all the genomic and molecular diagnostic tools that have come to the fore in the last decade.  It is not clear who will be the winner, but the stakes are global and large. Emergency life saving diagnostics can command a premium in the market, especially deaths related to COVID infections.  Understand the different drivers of this huge global diagnostic market and where the opportunity lies.

Our facts and support = Your success.
The report forecasts the market size out to 2025. Growth is coming from the basic factors but the COVID Pandemic has changed to market landscape now and for the foreseeable future.  Some players have already made their mark but disruptive diagnostic technology could change the playing field.  Learn about this market including the issues and outlooks.  The two key trends of Rapid Diagnositic and the Genomics Revolution are merging to create new diagnostic opportunities.

Our research makes you the expert in your organization. Get our research team working for you by ordering this comprehensive report.  Your credit card order sends the report to your inbox instantly.  Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to a wider license. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges. 

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.